Pricing now scales with dose, so people on lower starting doses pay less. The new Mochi Labs bloodwork service tracks A1C, cholesterol and thyroid, though not in NY, NJ, RI or HI.
Recap by typeshit. Full story at The Desert Sun.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Dr David Barzilai traced the development records of popular compounds and found many trace back to pharmaceutical companies.
The country's health regulator has cleared the oral version of Novo Nordisk's semaglutide for weight management.
Loading…